Pharmaceutical R&D organizations are under increasing pressure to deliver innovative therapies while managing growing levels of investment. Despite scientific breakthroughs, new technologies, and expanding R&D budgets, many companies struggle to translate their innovation potential into predictable and sustainable pipeline success. Often, the root causes are not a lack of talent, ideas, or resources, but structural challenges embedded across the R&D system. 

In our new whitepaper “Why Pharma R&D Struggles to Deliver – and How Leading Organizations Respond” we explore four frequently overlooked challenges that limit R&D performance: weak pipeline inflow, low productivity despite high investment, increasing clinical complexity, and fragmented data environments. We also examinewhy many transformation and optimization programs fail to deliver lasting impact and how leading organizations are addressing these challenges through a more integrated, system-level approach. 

The paper introduces Santiago Advisors’ Pipeline Success Engine, a framework designed to connect strategy, decision-making, and execution across the entire R&D value chain. By reducing organizational friction, improving transparency, and enabling faster, evidence-based decisions, the approach helps organizations strengthen pipeline quality, accelerate development, and improve overall R&D performance.

The whitepaper is intended for leaders and decision-makers across the pharmaceutical, biotech, and life sciences industries who are looking to increase the effectiveness of their R&D organizations and unlock greater value from innovation investments.

The whitepaper is now available for download:

https://go-santiago-advisors.com/whitepaper/